Effect of lycopene on insulin-like growth factor-I, IGF binding protein-3 and IGF type-I receptor in prostate cancer cells

Journal of Cancer Research and Clinical Oncology

Volumn 133, Issue 6, 2007, Pages 351-359

  Kanagaraj, P ^a   Vijayababu, M R ^a   Ravisankar, B ^a   Anbalagan, J ^a   Aruldhas, M M ^a   Arunakaran, J ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

IGF I; IGF IR; IGFBP 3; Lycopene; Prostate cancer

Indexed keywords

LIPOCORTIN 5; LYCOPENE; PROPIDIUM IODIDE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RISK; CELL PROLIFERATION; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA;

ANNEXIN A5; APOPTOSIS; CAROTENOIDS; CELL PROLIFERATION; DNA FRAGMENTATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PROPIDIUM; PROSTATIC NEOPLASMS; RECEPTOR, IGF TYPE 1; TUMOR CELLS, CULTURED;

EID: 34248208035     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-006-0177-6     Document Type: Article

References (40)

1. Angelloz-Nicoud P, Binoux M (1995) Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology 136:5485-5492
2. Chan M, Stampfer J, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563-566
3. Chaudhary KS, Abel PD, Stamp GWH, Lalani E (2001) Differential expression of cell death regulators in response to thapsigargin and adriamycin in Bcl-2 transfected DU145 prostatic cancer cells. J Pathol 193:522-529
4. Gerster H (1997) The potential role of lycopene for human health. J Am Coll Nutr 16:109-126
5. Giovannucci E (2002) A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp Biol Med 227:852-859
6. Hall AK (1996) Liarozole amplifies retinoid-induced apoptosis in human prostate cells. Anticancer Drugs 7:312-320
7. Hantz HL, Young LF, Martin KR (2005) Physiologically attainable concentration of lycopene induced mitochondrial apoptosis in LNCaP human prostate cancer cells. Exp Biol Med 2030:171-179
8. Huynh H, Yang X, Pollak M (1996) Estradiol and anti-estrogens regulate a growth inhibitory insulin-like growth factor binding protein-3 autocrine loop in human breast cancer cells. J Biol Chem 271:1061-1021
9. 3 and its analog EB1089. Int J Oncol 13:137-143
10. Hwang ES, Bowen PE (2005) Effects of tomato paste extracts on cell proliferation, cell-cycle arrest and apoptosis in LNCaP human prostate cancer cells. Biofactors 23:75-84
11. Iwamura M, Sluss PM, Casamento JB, Cockett AT (1993) Insulin-like growth factor-I: action and receptor characterization in human prostate cell lines. Prostate 22:243-252
12. Kaicer E, Blat C, Harel L (1991) IGF-I and IGF binding proteins: stimulatory and inhibitory factors secreted by human prostatic adenocarcinoma cells. Growth Factors 4:231-237
13. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17:16-23
14. Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahum A, Koifmann A, Giat Y, Levy J, Sharoni Y (2000) Lycopene interfere with cell cycle progression and insulin-like growth factor-I signaling in mammary cancer. Nutr Cancer 36:101-111
15. Kelin RD, Fischer SM (2002) Black tea polyphenols inhits IGF-I induced signal pathway through Akt in normal prostate epithelial cells and DU 145 prostate carcinoma cells. Carcinogenesis 23:217-221
16. Kim L, Rao AV, Rao LG (2002) Effect of lycopene on prostate LNCaP cancer cells in culture. J Med Food 5:181-187
17. Kimura G, Kasuva J, Giannini S, Honda Y, Mohan S, Kawachi M, Akimoto M, Fujita-Yamaguchi Y (1996) Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells. Int J Urol 3:39-46
18. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415-1420
19. Kotake-Nara E, Kushiro M, Zhang H, Sugawara T, Miyashita K, Nagao A (2001) Carotenoids affect proliferation of human prostate cells. J Nutr 131:3303-3306
20. Kotake-Nara E, Kim SJ, Kobori M, Miyashita K, Nagao A (2002) Acyclo-retinoic acid induces apoptosis in human prostate cancer cells. Anticancer Res 22:689-695
21. Liu C, Lian F, Smith DE, Russell RM, Wang XD (2003) Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed Ferrets. Cancer Res 63:3138-3144
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
23. Miles LEM, Lipschitz DA, Bieber CP, Cook JD (1974) Measurement of serum ferritin by a 2-site immunoradiometric assay. Anal Biochem 61:209-224
24. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 16:55-63
25. Newling DW (1996a) Anti-androgens in the treatment of prostate cancer. Br J Urol 7:776-784
26. Newling DW (1996b) The management of hormone refractory prostate cancer. Eur Urol 29:69-74
27. Park YO, Hwang ES, Moon TW (2005) The effect of lycopene on cell growth and oxidative DNA damage of Hep3B human hepatoma cells. Biofactors 23:129-139
28. Pastori M, Pfander H, Boscoboinik D, Azzi A (1998) Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells. Biochem Biophys Res Commun 250:582-585
29. Pietrzkowski Z, Mulholland G, Goomella L, Jameson BA, Wernicke D, Baserga B (1993) Inhibition of growth of prostate cancer cell lines by peptide analogue of insulin-like growth factor I. Cancer Res 53:1102-1106
30. Rajah R, Valentinis B, Cohen P (1997) Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53 and IGF-independent mechanism. J Biol Chem 272:12181-12188
31. Rajah R, Khare A, Lee PD, Cohen P (1999) Insulin-like growth factor-binding protein-3 is partially responsible for high-serum-induced apoptosis in PC-3 prostate cancer cells. J Endocrinol 163:487-494
32. Scher HI, Steineck G, Kelly WK (1995) Hormone refractory (D3) prostate cancer: refining the concept. Urology 46:142-148
33. Tang L, Jin T, Zeng X, Wang JS (2005) Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice. J Nutr 135:287-290
34. Vainas IG (2001) Octreotide in the management of hormone-refractory prostate cancer. Chemotherapy 47:109-129
35. Vijayababu MR, Kanagaraj P, Arunkumar A, Ilangovan R, Aruldhas MM, Arunakaran J (2005) Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. J Cancer Res Clin Oncol 131:765-771
36. Vijayababu MR, Kanagaraj P, Arunkumar A, Ilanagovan R, Dharmarajan A, Arunakaran J (2006) Quercetin induces p53-independent apoptosis in human prostate cancer cells by modulating Bcl-2 related proteins: a possible mediation by IGFBP-3. Oncol Res 16:67-74
37. Wetterau LA, Francis MJ, Ma L, Cohen P (2003) Insulin-like growth factor I stimulates telomerase activity in prostate cancer cells. J Clin Endocrinol Metab 88:3354-3359
38. Wolk A, Mantzoros CS, Andersson SO, Bergstrom R, Signorello LB, Lagiou P, Adami HO, Trichopoulos D (1998) Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 17:911-915
39. Zhang J, Jung K, Lein M, Kristiansen G, Rudolph B, Hauptmann S, Schnorr D, Loening SA, Lichtinghagen R (2002) Differential expression of matrix metalloproteinases and their tissue inhibitors. Prostate 50:38-45
40. Zi X, Zhang J, Agarwal R, Pollak M (2000) Silibinin up-regulates insulin-like growth factor-binding protein-3 expression and inhibits proliferation of androgen-independent prostate cancer cells. Cancer Res 60:5617-5620